Pinsent Masons tops the AIM Advisers Rankings Guide

08 Aug 2013 | 05:07 pm |

International law firm Pinsent Masons has retained first place in the latest AIM Advisers Rankings guide, with a total of 56 clients quoted on the junior market.

The firm won a total of seven new clients in the industrial, consumer goods and services, technology and oil and gas sectors with three new clients won in the latter.

New additions include biopharmaceuticals company Valirx Plc and Latin American power company Rurelec Plc.

Pinsent Masons’ corporate partner and capital markets specialist, Sean Page, said:

"Our AIM expertise has enabled us to dominate the rankings for some time. It's good to see that we continue to secure new clients both domestic and international despite challenging market conditions.

"Our capital markets practice is based around our sector-led proposition and breadth of coverage – maintaining our number one AIM ranking also being ranked second for all quoted clients is a testament to this approach."

Earlier this year, the firm capitalised on its experience in both the main and junior markets advising AIM-quoted manufacturer Tyman Plc on its $200 million acquisition of Truth Hardware moving up to the London Stock Exchange (LSE) main market.

Latest press releases

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons secures 11th place in Financial Times Diversity Leaders 2021 Report

Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts